Researchers identify potential nanotechnology therapy for rare, incurable bone cancer
Researchers identify potential nanotechnology therapy for rare, incurable bone cancer
DCprime Presents Comprehensive Preclinical Results Supporting Lead Clinical Candidate DCP-001
DCprime Presents Comprehensive Preclinical Results Supporting Lead Clinical Candidate DCP-001
Regeneration mechanism discovered in mice could provide target for drugs to combat chronic liver...
Regeneration mechanism discovered in mice could provide target for drugs to combat chronic liver disease
New Study Demonstrates a Unique Role of Nicotinamide Riboside Over Other NAD Precursors
New Study Demonstrates a Unique Role of Nicotinamide Riboside Over Other NAD Precursors
QED and Parent Company BridgeBio Announce Preclinical Data Supporting Tolerability and Activity of Low-dose...
QED and Parent Company BridgeBio Announce Preclinical Data Supporting Tolerability and Activity of Low-dose Infigratinib in Treating Achondroplasia
